bupropion has been researched along with atomoxetine hydrochloride in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (54.29) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 4 (11.43) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Biederman, J; Faraone, SV; Spencer, TJ; Wilens, TE | 1 |
| Pliszka, SR | 1 |
| Maidment, ID | 1 |
| Biederman, J; Spencer, T; Wilens, T | 1 |
| Wilens, TE | 2 |
| Reeves, G; Schweitzer, J | 1 |
| Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A | 1 |
| Waxmonsky, JG | 1 |
| Arnsten, AF; Biederman, J; Culpepper, L; Doyle, AE; Faraone, SV; Safren, SA; Spencer, TJ; Weiss, MD; Wilens, TE | 1 |
| Culpepper, L | 1 |
| Dewan, M; Faraone, SV; Kunwar, A | 1 |
| Bevins, RA; Linkugel, JD; Reichel, CM | 1 |
| Fu, R; McDonagh, MS; Peterson, K | 1 |
| Bálint, S; Bitter, I; Czobor, P; Mészáros, A; Simon, V | 1 |
| Holdridge, KC; Hornbuckle, K; Johannes, CB; McAfee, AT; Walker, AM | 1 |
| Daughton, JM; Kratochvil, CJ | 1 |
| Silva, RR | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Cools, AR; Deen, PM; Ellenbroek, BA; Olivier, B; Olivier, JD | 1 |
| Faraone, SV; Glatt, SJ | 1 |
| Chakraborty, B; Manniche, PM; Meier, D; Schoedel, KA; Sellers, EM | 1 |
| Canagaratnam, M; Santosh, PJ; Sattar, S | 1 |
| Araki, H; Kawasaki, H; Suemaru, K; Takechi, K | 1 |
| Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R | 1 |
| Alexander, GC; Conti, RM; Dorsey, ER; Dusetzina, SB; Garfield, CF; Higashi, AS; Huskamp, HA; Kornfield, R; Watson, S | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Locatelli, I; Munda, B; Stuhec, M; Svab, V | 1 |
| Su, CC; Tsai, CY; Tsai, IJ; Tsai, TH | 1 |
| Anagnostaras, SG; Carmack, SA; Hammam, L; Pantoni, MM | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
21 review(s) available for bupropion and atomoxetine hydrochloride
| Article | Year |
|---|---|
Novel treatments for attention-deficit/hyperactivity disorder in children.
Topics: Adolescent; Age Factors; Amphetamine; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Administration Schedule; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Propylamines; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors | 2002 |
Non-stimulant treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bupropion; Child; Clinical Trials as Topic; Humans; Modafinil; Practice Guidelines as Topic; Propylamines; Treatment Outcome | 2003 |
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Cyclohexanols; Humans; Propylamines; Venlafaxine Hydrochloride | 2003 |
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Evidence-Based Medicine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
Impact of ADHD and its treatment on substance abuse in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Humans; Propylamines; Psychotherapy; Risk Factors; Self Medication; Substance-Related Disorders | 2004 |
Pharmacological management of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines | 2005 |
Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Benzhydryl Compounds; Bupropion; Child; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Modafinil; Propylamines; Psychotherapy; Psychotropic Drugs | 2005 |
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Nicotinic Antagonists; Pharmacogenetics; Propylamines | 2006 |
Primary care treatment of attention-deficit/hyperactivity disorder.
Topics: Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Bupropion; Central Nervous System Stimulants; Child; Combined Modality Therapy; Comorbidity; Family Health; Humans; Parents; Physicians, Family; Primary Health Care; Professional-Family Relations; Propylamines; Psychiatric Status Rating Scales; Psychotherapy; Teaching | 2006 |
Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Comorbidity; Depressive Disorder, Major; Humans; Mental Disorders; Prevalence; Propylamines | 2007 |
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
Topics: Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Humans; Propylamines; Psychotropic Drugs; Treatment Outcome | 2008 |
[Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Propylamines | 2007 |
Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.
Topics: Adolescent; Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Costs; Humans; Propylamines; Treatment Outcome; United States; United States Food and Drug Administration | 2009 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Medication Adherence; Placebos; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Search Engine; Treatment Outcome | 2010 |
Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Humans; Propylamines; Treatment Outcome | 2011 |
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Dextroamphetamine; Diagnostic Self Evaluation; Educational Status; Female; Humans; Interpersonal Relations; Interview, Psychological; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Neuropsychological Tests; Occupations; Propylamines; Quality of Life; Severity of Illness Index; Symptom Assessment | 2012 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comparative Effectiveness Research; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Acceptance of Health Care; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
1 trial(s) available for bupropion and atomoxetine hydrochloride
| Article | Year |
|---|---|
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Atomoxetine Hydrochloride; Attention; Biogenic Monoamines; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Hemodynamics; Humans; Male; Middle Aged; Propylamines; Psychomotor Performance; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Young Adult | 2010 |
13 other study(ies) available for bupropion and atomoxetine hydrochloride
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
New developments in the treatment of ADHD.
Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Cognitive Behavioral Therapy; Guanfacine; Humans; Modafinil; Nicotinic Agonists; Physician's Role; Primary Health Care; Propylamines; Treatment Outcome | 2006 |
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Bupropion; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Methylphenidate; Nicotine; Nicotinic Antagonists; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley | 2007 |
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Consumer Product Safety; Databases as Topic; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Insurance Claim Reporting; Logistic Models; Male; Odds Ratio; Propylamines; Retrospective Studies; Risk Assessment; Risk Factors; Seizures; United States | 2008 |
Two recent updates for psychiatric conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |
Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters.
Topics: Animals; Atomoxetine Hydrochloride; Body Temperature; Bupropion; Dopamine Plasma Membrane Transport Proteins; Fever; Injections; Male; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Propylamines; Rats; Serotonin Plasma Membrane Transport Proteins; Stress, Physiological | 2010 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; Depression; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Propylamines; Seizures; Swimming | 2011 |
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Dopamine Uptake Inhibitors; Drug Utilization; Guanfacine; Humans; Practice Patterns, Physicians'; Propylamines; United States; United States Food and Drug Administration | 2013 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cohort Studies; Databases, Factual; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Methylphenidate; National Health Programs; Risk Factors; Taiwan; Visual Acuity | 2019 |
Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement.
Topics: Animals; Atomoxetine Hydrochloride; Behavior, Animal; Bupropion; Central Nervous System Stimulants; Conditioning, Classical; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Fear; Female; Fluoxetine; Male; Memory, Long-Term; Mice; Mice, Inbred C57BL; Neurotransmitter Uptake Inhibitors; Nootropic Agents; Norepinephrine Plasma Membrane Transport Proteins | 2020 |
Adult attention deficit/hyperactivity disorder in the ambulatory care setting: Erratum.
Topics: Ambulatory Care; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Contraindications, Drug; Dopamine; Feeding and Eating Disorders; Humans; Methylphenidate; Norepinephrine | 2020 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |